Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68: 394–424.
   PubMed Web of Science ®Google Scholar
• Araghi M, Soerjomataram I, Jenkins M, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019; 144: 2992–3000.
   PubMed Web of Science ®Google Scholar
• Kanth P, Grimmett J, Champine M, et al. Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol 2017;112:1509–25.
   PubMed Web of Science ®Google Scholar
• Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 2019;16:361–75.
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W, German Rectal Cancer Study Group, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40.
   PubMed Web of Science ®Google Scholar
• Bruheim K, Guren MG, Skovlund E, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010;76:1005–11.
   PubMed Web of Science ®Google Scholar
• Van der Jeught K, Xu HC, Li YJ, et al. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 2018;24:3834–48.
   PubMed Web of Science ®Google Scholar
• Donati B, Lorenzini E, Ciarrocchi A. BRD4 and cancer: going beyond transcriptional regulation. Mol Cancer 2018;17:164.
   PubMed Web of Science ®Google Scholar
• White ME, Fenger JM, Carson WE. 3rd,. Emerging roles of and therapeutic strategies targeting BRD4 in cancer. Cell Immunol 2019;337:48–53.
   PubMed Web of Science ®Google Scholar
• Otto C, Schmidt S, Kastner C, et al. Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells. Neoplasia 2019;21:1110–20.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature 2010;468:1067–73.
   PubMed Web of Science ®Google Scholar
• Rodrigues T, Reker D, Schneider P, et al. Counting on natural products for drug design. Nat Chem 2016;8:531–41.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016;79:629–61.
   PubMed Web of Science ®Google Scholar
• Matulja D, Wittine K, Malatesti N, et al. Marine natural products with high anticancer activities. Curr Med Chem 2020;27:1243–307.
   PubMed Web of Science ®Google Scholar
• Vazquez-Rodriguez S, Matos MJ, Borges F, et al. Bioactive coumarins from marine sources: origin, structural features and pharmacological properties. Curr Top Med Chem 2015;15:1755–66.
   PubMed Web of Science ®Google Scholar
• Costa TM, Tavares LBB, de Oliveira D. Fungi as a source of natural coumarins production. Appl Microbiol Biotechnol 2016;100:6571–84.
   PubMed Web of Science ®Google Scholar
• Miura K, Satoh M, Kinouchi M, et al. The use of natural products in colorectal cancer drug discovery. Exp Opin Drug Disc 2015;10:411–26.
   PubMed Web of Science ®Google Scholar
• Kaur M, Kohli S, Sandhu S, et al. Coumarin: a promising scaffold for anticancer agents. Anticancer Agents Med Chem 2015;15:1032–48.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu Z. Coumarin-containing hybrids and their anticancer activities. Eur J Med Chem 2019;181:111587.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27:963–70.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Coumarin carbonic anhydrase inhibitors from natural sources. J Enzyme Inhib Med Chem 2020;35:1462–70.
   PubMed Web of Science ®Google Scholar
• Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Fois B, Distinto S, Meleddu R, et al. Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation. J Enzyme Inhib Med Chem 2020;35:539–48.
   PubMed Web of Science ®Google Scholar
• Cai G, Yu W, Song D, et al. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors. Eur J Med Chem 2019;174:236–51.
   PubMed Web of Science ®Google Scholar
• Govindaiah P, Dumala N, Mattan I, et al. Design, synthesis, biological and in silico evaluation of coumarin-hydrazone derivatives as tubulin targeted antiproliferative agents. Bioorg Chem 2019;91:103143.
   PubMed Web of Science ®Google Scholar
• Liu H, Ren ZL, Wang W, et al. Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: Design, synthesis and antibacterial activity. Eur J Med Chem 2018;157:81–7.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gu L, Wang B, et al. Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping. J Enzyme Inhib Med Chem 2019;34:808–17.
   PubMed Web of Science ®Google Scholar
• Duan YC, Zheng YC, Li XC, et al. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids. Eur J Med Chem 2013;64:99–110.
   PubMed Web of Science ®Google Scholar
• Cao SL, Wang Y, Zhu L, et al. Synthesis and cytotoxic activity of N-((2-methyl-4(3H)-quinazolinon-6-yl)methyl)dithiocarbamates. Eur J Med Chem 2010;45:3850–7.
   PubMed Web of Science ®Google Scholar
• Xie R, Li Y, Tang P, et al. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents. Eur J Med Chem 2018;143:320–33.
   PubMed Web of Science ®Google Scholar
• Yang CR, Peng B, Cao SL, et al. Synthesis, cytotoxic evaluation and target identification of thieno[2,3-d]pyrimidine derivatives with a dithiocarbamate side chain at C2 position. Eur J Med Chem 2018;154:324–40.
   PubMed Web of Science ®Google Scholar
• Mostafa AS, Selim KB. Synthesis and anticancer activity of new dihydropyrimidinone derivatives. Eur J Med Chem 2018;156:304–15.
   PubMed Web of Science ®Google Scholar
• Li RD, Wang HL, Li YB, et al. Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents. Eur J Med Chem 2015;93:381–91.
   PubMed Web of Science ®Google Scholar
• Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun 2012;48:1868–70.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
• Zeidan MA, Mostafa AS, Gomaa RM, et al. Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors. Eur J Med Chem 2019;168:315–29.
   PubMed Web of Science ®Google Scholar
• Su Y, Li R, Ning X, et al. Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. Eur J Med Chem 2019;177:32–46.
   PubMed Web of Science ®Google Scholar
• Vodenkova S, Buchler T, Cervena K, et al. 5-Fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther 2020;206:107447.
   PubMed Web of Science ®Google Scholar
• Wu J, Yi J, Wu Y, et al. 3, 3'-Dimethylquercetin inhibits the proliferation of human colon cancer RKO cells through inducing G2/M cell cycle arrest and apoptosis. Anticancer Agents Med. Chem 2019;19:402–9.
   PubMed Web of Science ®Google Scholar
• Draetta G, Beach D. The mammalian cdc2 protein kinase: mechanisms of regulation during the cell cycle. J Cell Sci Suppl 1989;12:21–7.
   PubMedGoogle Scholar
• Bruckheimer EM, Cho SH, Sarkiss M, et al. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol 1998;62:75–105.
   PubMedGoogle Scholar
• Dawson MA, Prinjha RK, Dittmann A, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011; 478:529–33.
   PubMed Web of Science ®Google Scholar